vs
ASTEC INDUSTRIES INC（ASTE）与Prestige Consumer Healthcare Inc.（PBH）财务数据对比。点击上方公司名可切换其他公司
ASTEC INDUSTRIES INC的季度营收约是Prestige Consumer Healthcare Inc.的1.4倍（$400.6M vs $283.4M），Prestige Consumer Healthcare Inc.净利率更高（16.5% vs 3.0%，领先13.5%），ASTEC INDUSTRIES INC同比增速更快（11.6% vs -2.4%），Prestige Consumer Healthcare Inc.自由现金流更多（$75.3M vs $7.4M），过去两年ASTEC INDUSTRIES INC的营收复合增速更高（13.8% vs 1.2%）
ASTEC是一家国际电子企业，原总部设于香港，主营电源供应装置与电力转换硬件产品，是全球计算机系统电源的主要供应商之一，曾一度是全球规模最大的电源生产商。
Prestige Consumer Healthcare Inc.是一家美国企业，主营非处方健康护理产品及家用清洁产品的营销与分销业务。该公司于1996年由Medtech Products、Prestige Brands International及Spic and Span三家公司合并成立，总部位于纽约州塔里敦，在弗吉尼亚州林奇堡设有生产工厂。
ASTE vs PBH — 直观对比
营收规模更大
ASTE
是对方的1.4倍
$283.4M
营收增速更快
ASTE
高出14.0%
-2.4%
净利率更高
PBH
高出13.5%
3.0%
自由现金流更多
PBH
多$67.9M
$7.4M
两年增速更快
ASTE
近两年复合增速
1.2%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $400.6M | $283.4M |
| 净利润 | $12.0M | $46.7M |
| 毛利率 | 27.3% | 55.5% |
| 营业利润率 | 5.7% | 29.1% |
| 净利率 | 3.0% | 16.5% |
| 营收同比 | 11.6% | -2.4% |
| 净利润同比 | -43.1% | -23.5% |
| 每股收益（稀释后） | $0.52 | $0.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTEPBH
| Q4 25 | $400.6M | $283.4M | ||
| Q3 25 | $350.1M | $274.1M | ||
| Q2 25 | $330.3M | $249.5M | ||
| Q1 25 | $329.4M | $296.5M | ||
| Q4 24 | $359.0M | $290.3M | ||
| Q3 24 | $291.4M | $283.8M | ||
| Q2 24 | $345.5M | $267.1M | ||
| Q1 24 | $309.2M | $277.0M |
净利润ASTEPBH
| Q4 25 | $12.0M | $46.7M | ||
| Q3 25 | $-4.2M | $42.2M | ||
| Q2 25 | $16.7M | $47.5M | ||
| Q1 25 | $14.3M | $50.1M | ||
| Q4 24 | $21.1M | $61.0M | ||
| Q3 24 | $-6.2M | $54.4M | ||
| Q2 24 | $-14.0M | $49.1M | ||
| Q1 24 | $3.4M | $49.5M |
毛利率ASTEPBH
| Q4 25 | 27.3% | 55.5% | ||
| Q3 25 | 24.1% | 55.3% | ||
| Q2 25 | 26.7% | 56.2% | ||
| Q1 25 | 28.1% | 57.3% | ||
| Q4 24 | 28.7% | 55.5% | ||
| Q3 24 | 22.9% | 55.5% | ||
| Q2 24 | 23.5% | 54.7% | ||
| Q1 24 | 24.9% | 54.8% |
营业利润率ASTEPBH
| Q4 25 | 5.7% | 29.1% | ||
| Q3 25 | 0.3% | 29.1% | ||
| Q2 25 | 6.5% | 28.8% | ||
| Q1 25 | 6.2% | 29.8% | ||
| Q4 24 | 9.7% | 31.7% | ||
| Q3 24 | -2.5% | 29.7% | ||
| Q2 24 | -3.1% | 27.0% | ||
| Q1 24 | 2.0% | 29.7% |
净利率ASTEPBH
| Q4 25 | 3.0% | 16.5% | ||
| Q3 25 | -1.2% | 15.4% | ||
| Q2 25 | 5.1% | 19.0% | ||
| Q1 25 | 4.3% | 16.9% | ||
| Q4 24 | 5.9% | 21.0% | ||
| Q3 24 | -2.1% | 19.2% | ||
| Q2 24 | -4.1% | 18.4% | ||
| Q1 24 | 1.1% | 17.9% |
每股收益（稀释后）ASTEPBH
| Q4 25 | $0.52 | $0.97 | ||
| Q3 25 | $-0.18 | $0.86 | ||
| Q2 25 | $0.72 | $0.95 | ||
| Q1 25 | $0.62 | $1.00 | ||
| Q4 24 | $0.92 | $1.22 | ||
| Q3 24 | $-0.27 | $1.09 | ||
| Q2 24 | $-0.61 | $0.98 | ||
| Q1 24 | $0.15 | $0.98 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.1M | $62.4M |
| 总债务越低越好 | — | $1.0B |
| 股东权益账面价值 | $681.7M | $1.8B |
| 总资产 | $1.4B | $3.5B |
| 负债/权益比越低杠杆越低 | — | 0.56× |
8季度趋势，按日历期对齐
现金及短期投资ASTEPBH
| Q4 25 | $74.1M | $62.4M | ||
| Q3 25 | $71.8M | $119.1M | ||
| Q2 25 | $91.6M | $139.5M | ||
| Q1 25 | $95.4M | $97.9M | ||
| Q4 24 | $93.8M | $50.9M | ||
| Q3 24 | $58.9M | $51.5M | ||
| Q2 24 | $68.4M | $34.3M | ||
| Q1 24 | $63.8M | $46.5M |
总债务ASTEPBH
| Q4 25 | — | $1.0B | ||
| Q3 25 | — | $993.1M | ||
| Q2 25 | — | $992.7M | ||
| Q1 25 | — | $992.4M | ||
| Q4 24 | — | $992.0M | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $1.1B |
股东权益ASTEPBH
| Q4 25 | $681.7M | $1.8B | ||
| Q3 25 | $668.9M | $1.8B | ||
| Q2 25 | $674.9M | $1.9B | ||
| Q1 25 | $653.2M | $1.8B | ||
| Q4 24 | $637.8M | $1.8B | ||
| Q3 24 | $631.4M | $1.7B | ||
| Q2 24 | $633.3M | $1.7B | ||
| Q1 24 | $650.3M | $1.7B |
总资产ASTEPBH
| Q4 25 | $1.4B | $3.5B | ||
| Q3 25 | $1.3B | $3.4B | ||
| Q2 25 | $1.1B | $3.4B | ||
| Q1 25 | $1.1B | $3.4B | ||
| Q4 24 | $1.0B | $3.3B | ||
| Q3 24 | $1.1B | $3.3B | ||
| Q2 24 | $1.1B | $3.3B | ||
| Q1 24 | $1.1B | $3.3B |
负债/权益比ASTEPBH
| Q4 25 | — | 0.56× | ||
| Q3 25 | — | 0.54× | ||
| Q2 25 | — | 0.54× | ||
| Q1 25 | — | 0.54× | ||
| Q4 24 | — | 0.55× | ||
| Q3 24 | — | 0.61× | ||
| Q2 24 | — | 0.65× | ||
| Q1 24 | — | 0.68× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $36.1M | $78.3M |
| 自由现金流经营现金流 - 资本支出 | $7.4M | $75.3M |
| 自由现金流率自由现金流/营收 | 1.8% | 26.6% |
| 资本支出强度资本支出/营收 | 7.2% | 1.1% |
| 现金转化率经营现金流/净利润 | 3.01× | 1.68× |
| 过去12个月自由现金流最近4个季度 | $20.7M | $267.2M |
8季度趋势，按日历期对齐
经营现金流ASTEPBH
| Q4 25 | $36.1M | $78.3M | ||
| Q3 25 | $-8.1M | $57.5M | ||
| Q2 25 | $12.9M | $79.0M | ||
| Q1 25 | $20.5M | $61.8M | ||
| Q4 24 | $36.6M | $65.1M | ||
| Q3 24 | $22.5M | $69.8M | ||
| Q2 24 | $10.9M | $54.8M | ||
| Q1 24 | $-47.0M | $66.9M |
自由现金流ASTEPBH
| Q4 25 | $7.4M | $75.3M | ||
| Q3 25 | $-12.3M | $55.4M | ||
| Q2 25 | $9.0M | $78.2M | ||
| Q1 25 | $16.6M | $58.4M | ||
| Q4 24 | $32.1M | $63.5M | ||
| Q3 24 | $19.9M | $67.8M | ||
| Q2 24 | $3.3M | $53.6M | ||
| Q1 24 | $-52.8M | $63.8M |
自由现金流率ASTEPBH
| Q4 25 | 1.8% | 26.6% | ||
| Q3 25 | -3.5% | 20.2% | ||
| Q2 25 | 2.7% | 31.3% | ||
| Q1 25 | 5.0% | 19.7% | ||
| Q4 24 | 8.9% | 21.9% | ||
| Q3 24 | 6.8% | 23.9% | ||
| Q2 24 | 1.0% | 20.1% | ||
| Q1 24 | -17.1% | 23.0% |
资本支出强度ASTEPBH
| Q4 25 | 7.2% | 1.1% | ||
| Q3 25 | 1.2% | 0.8% | ||
| Q2 25 | 1.2% | 0.3% | ||
| Q1 25 | 1.2% | 1.2% | ||
| Q4 24 | 1.3% | 0.5% | ||
| Q3 24 | 0.9% | 0.7% | ||
| Q2 24 | 2.2% | 0.4% | ||
| Q1 24 | 1.9% | 1.1% |
现金转化率ASTEPBH
| Q4 25 | 3.01× | 1.68× | ||
| Q3 25 | — | 1.36× | ||
| Q2 25 | 0.77× | 1.66× | ||
| Q1 25 | 1.43× | 1.23× | ||
| Q4 24 | 1.73× | 1.07× | ||
| Q3 24 | — | 1.28× | ||
| Q2 24 | — | 1.12× | ||
| Q1 24 | -13.82× | 1.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTE
| Infrastructure Group | $208.7M | 52% |
| Material Solutions | $105.3M | 26% |
| Parts And Component Sales | $58.3M | 15% |
| Other | $15.3M | 4% |
| Service And Equipment Installation Revenue | $6.9M | 2% |
| Cargo And Freight | $6.1M | 2% |
PBH
| Womens Health | $51.8M | 18% |
| International OTC Healthcare | $47.7M | 17% |
| Gastrointestinal | $44.2M | 16% |
| Eye And Ear Care | $35.2M | 12% |
| Dermatologicals | $27.6M | 10% |
| Analgesics | $26.7M | 9% |
| Oral Care | $23.5M | 8% |
| Cough And Cold | $23.0M | 8% |
| Other Otc | $3.6M | 1% |
